Mandatory notice of trades in IDEX – board remuneration in shares
IDEX ASA issues this notice on behalf of the primary insiders below. Following the annual general meeting of IDEX on 9 May 2018, chairman Morten Opstad and board members Larry Ciaccia, Deborah Davis and Andy MacLeod elected to receive part or full board remuneration in shares.
Chairman Morten Opstad will acquire 49,720 shares against payment of NOK 0.15 per share, instead of NOK 160,000 of the board remuneration. Mr Opstad will take the remainder of the board remuneration in cash. After this transaction, Mr Opstad and close associates will hold 7,198,916 shares in IDEX.
Board member Larry Ciaccia will acquire 88,563 shares against payment of NOK 0.15 per share, instead of NOK 285,000 of the board remuneration. Mr Ciaccia will take the remainder of the board remuneration in cash. After this transaction, Mr Ciaccia will hold 121,563 shares and 500,000 incentive subscription rights in IDEX.
Board member Deborah Davis will acquire 93,224 shares against payment of NOK 0.15 per share, instead of receiving a cash board remuneration of NOK 300,000. After this transaction, Ms Davis will hold 199,115 shares and no other rights to shares in IDEX.
Board member Andy Macleod will acquire 68,675 shares against payment of NOK 0.15 per share, instead of NOK 221,000 of the board remuneration. Mr MacLeod will take the remainder of the board remuneration in cash. After this transaction, Mr MacLeod will hold 553,475 shares and 500,000 incentive subscription rights in IDEX.
Contact:
Charlotte Knudsen, Director of IR and Communications, +47 9756 1959, ck@idexbiometrics.com
About IDEX
IDEX is a leading developer of advanced off-chip fingerprint sensors and complete system solutions to a range of biometrically-enabled applications, including smart cards, Internet of Things (IoT) and mobile. The company’s technology is based on a fundamentally unique architecture that delivers form factor flexibility and superior cost-performance characteristics. IDEX’s total addressable market represents a fast-growing multi-billion unit opportunity.
IDEX ASA is traded on the Oslo stock exchange under the ticker IDEX.
For more information please visit www.idexbiometrics.com and follow us on Twitter @IDEXASA
Chairman Morten Opstad will acquire 49,720 shares against payment of NOK 0.15 per share, instead of NOK 160,000 of the board remuneration. Mr Opstad will take the remainder of the board remuneration in cash. After this transaction, Mr Opstad and close associates will hold 7,198,916 shares in IDEX.
Board member Larry Ciaccia will acquire 88,563 shares against payment of NOK 0.15 per share, instead of NOK 285,000 of the board remuneration. Mr Ciaccia will take the remainder of the board remuneration in cash. After this transaction, Mr Ciaccia will hold 121,563 shares and 500,000 incentive subscription rights in IDEX.
Board member Deborah Davis will acquire 93,224 shares against payment of NOK 0.15 per share, instead of receiving a cash board remuneration of NOK 300,000. After this transaction, Ms Davis will hold 199,115 shares and no other rights to shares in IDEX.
Board member Andy Macleod will acquire 68,675 shares against payment of NOK 0.15 per share, instead of NOK 221,000 of the board remuneration. Mr MacLeod will take the remainder of the board remuneration in cash. After this transaction, Mr MacLeod will hold 553,475 shares and 500,000 incentive subscription rights in IDEX.
Contact:
Charlotte Knudsen, Director of IR and Communications, +47 9756 1959, ck@idexbiometrics.com
About IDEX
IDEX is a leading developer of advanced off-chip fingerprint sensors and complete system solutions to a range of biometrically-enabled applications, including smart cards, Internet of Things (IoT) and mobile. The company’s technology is based on a fundamentally unique architecture that delivers form factor flexibility and superior cost-performance characteristics. IDEX’s total addressable market represents a fast-growing multi-billion unit opportunity.
IDEX ASA is traded on the Oslo stock exchange under the ticker IDEX.
For more information please visit www.idexbiometrics.com and follow us on Twitter @IDEXASA
This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.
